Evidence map›Paper›PMID 39030965›Full record

ArticleAnnals of clinical and translational neurology2024

Epidemiology of autoimmune encephalitis and comparison to infectious causes-Experience from a tertiary center.

Yahel Segal, Ofer Rotschild, Yair Mina, Gadi Maayan Eshed, Tal Levinson, Yael Paran, Michal Dekel, Ronit Cohen-Poradosu, Adi Ashkenazi, Itamar Moreno and 4 more

Abstract readComparative Study
In one paragraph

Article in Annals of clinical and translational neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Changes in etiology, diagnostic challenges, and prognostic factors in pediatric acute encephalitis: Insights from an 18-year retrospective study.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Yahel Segal *Department of Neurology, Tel-Aviv Medical Center, Tel-Aviv, Israel.ORCID 0000-0001-6452-9526
Ofer Rotschild *Department of Neurology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Yair MinaDepartment of Neurology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Gadi Maayan EshedDepartment of Neurology, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Tal LevinsonInfectious Diseases Unit, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Yael ParanEncephalitis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Michal DekelEncephalitis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Ronit Cohen-PoradosuInfectious Diseases Unit, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Adi AshkenaziSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Itamar MorenoSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Orna AizensteinEncephalitis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Ora HalutzEncephalitis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Yifat AlcalayEncephalitis Center, Tel-Aviv Medical Center, Tel-Aviv, Israel.
Avi GadothDepartment of Neurology, Tel-Aviv Medical Center, Tel-Aviv, Israel.ORCID 0000-0003-1917-9349

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe incidence of autoimmune encephalitis (AIE) has risen in the last decade, yet recent studies are lacking. We compared the epidemiology of autoimmune and infectious encephalitis cases in Tel-Aviv Sourasky Medical Center (TASMC) between 2010 and 2020.

methodsAll encephalitis cases, aged 18 and above, admitted to TASMC between the years 2010 and 2020 were reviewed for demographic, clinical, laboratory, and imaging data and categorized based on etiology.

resultsTwo hundred and twenty-five patients with encephalitis were identified. The most common identifiable cause was viral (42%), followed by autoimmune encephalitis (35%), bacterial (18%), and fungal/parasitic (5%). The incidence of AIE cases out of the yearly admitted cases increased substantially, from 3.8/100 K in 2010 to 18.8/100 K in 2020. The incidence of viral cases also increased while those of bacterial and fungal/parasitic infections remained stable. Patients with AIE were younger compared to infectious patients (p-value <0.001) and had lower markers of systemic and cerebrospinal fluid inflammation (p-value for all <0.001). Seizures were more common among AIE patients (p-value <0.001), yet one-year mortality rates were higher among infectious patients (p-value <0.001).

interpretationAIE incidence has risen significantly in our institution during the past decade, with current rates comparable to those of all infectious causes combined. Based on this cohort, clinical clues for an autoimmune etiology include a non-inflammatory cerebrospinal fluid profile, the presence of seizures, and temporal lobe imaging abnormalities (also common in herpetic encephalitis). In light of its rising incidence and the importance of early treatment, AIE should be considered in the differential diagnosis of all encephalitis cases.

Indexed as

EncephalitisHashimoto DiseaseInfectious EncephalitisAdolescentAdultAgedAutoimmune Diseases of the Nervous SystemFemaleHumansIncidenceIsraelMaleMiddle AgedRetrospective StudiesTertiary Care CentersYoung Adult

Identifiers

PMID39030965
PMCPMC11537142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.